Search Results 121-130 of 21184 for Inhibition

1. First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors - Mayo Clinic

   TP-0903 is a novel oral inhibitor that targets AXL kinase. Preclinical studies have shown promising antitumor activity of TP-0903 as a single agent against a ...

2. Targeting Mesotrypsin in Breast, Prostate, Pancreatic and Lung Cancers - Proteases in Cancer Laboratory - Mayo Clinic Research

   ... inhibition by many inhibitors of other trypsins. Our lab has created prototype mesotrypsin inhibitors with improved affinity by using site-directed ...

3. Heartburn medicines and B-12 deficiency - Mayo Clinic

   Proton pump inhibitors. These include omeprazole (Prilosec), esomeprazole (Nexium) and lansoprazole (Prevacid). Some studies have found that taking either ...

4. Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension - Mayo Clinic

   Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension · Overview · Participation ...

5. A Study of 68GA-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure - Mayo Clinic

   A Study of 68GA-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure · Overview · Participation eligibility · Participating ...

6. Abatacept in Immune Checkpoint Inhibitor Myocarditis (ATRIUM) - Mayo Clinic

   ... inhibitor (ICI). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

7. A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors - Mayo Clinic

   Clinical Trials · A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors · More about research at Mayo ...

8. Selective Serotonin Inhibitor-Induced Changes in the Gut Microbiome in Depression - Mayo Clinic

   The purpose of this study is to uncover the main effects of selective serotonin inhibitor-induced (SSRI) therapy on the human microbiota, the relationship to ...

9. Clinical trials - Oncology (Medical)

   The purpose of this study is to evaluate ALPN-202 with PD-1 inhibition to treat adults with advanced solid tumors or lymphoma. A Study of Endometrial Cancer ...

10. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin ...